Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Onabotulinum toxin A for Bladder Pain Syndrome
2014-001013-81Phase 2Completed
- Sponsor
- Hospital de São João
- Start
- Jul 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of botulinum toxin type A in Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS) (2 arms), sponsored by Hospital de São João. Primary endpoint: Change in bladder pain intensity from baseline to week 12. Started Jul 2014; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS)
Beyond the preview
Go deeper on 2014-001013-81.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001013-81.